BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Clinical Outcome
6 results:

  • 1. A novel four‑snoRNA signature for predicting the survival of patients with uveal melanoma.
    Yi Q; Zou WJ
    Mol Med Rep; 2019 Feb; 19(2):1294-1301. PubMed ID: 30569172
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.
    Omari A; Nastały P; Stoupiec S; Bałabas A; Dąbrowska M; Bielińska B; Huss S; Pantel K; Semjonow A; Eltze E; Brandt B; Bednarz-Knoll N
    Int J Cancer; 2019 Feb; 144(3):607-614. PubMed ID: 30265376
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [clinical outcome of patients with gestational trophoblastic neoplasia receiving primary treatment at Peking Union Medical College Hospital: a 30-year retrospective cohort study].
    Jiang F; Yang Y; Ji ML; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):364-370. PubMed ID: 29961277
    [No Abstract]    [Full Text] [Related]  

  • 4. Pathology review of screening negative neuroblastomas: a report from the Quebec Neuroblastoma Screening Project.
    Kawakami T; Monobe Y; Monforte H; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD; Triche TJ; Shimada H
    Cancer; 1998 Aug; 83(3):575-81. PubMed ID: 9690552
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients.
    Vitolo U; Gaidano G; Botto B; Volpe G; Audisio E; Bertini M; Calvi R; Freilone R; Novero D; Orsucci L; Pastore C; Capello D; Parvis G; Sacco C; Zagonel V; Carbone A; Mazza U; Palestro G; Saglio G; Resegotti L
    Ann Oncol; 1998 Jan; 9(1):55-61. PubMed ID: 9541684
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.
    Offit K; Lo Coco F; Louie DC; Parsa NZ; Leung D; Portlock C; Ye BH; Lista F; Filippa DA; Rosenbaum A
    N Engl J Med; 1994 Jul; 331(2):74-80. PubMed ID: 8208268
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.